Born in April 1970, PhD, Chief Physician, recognized as a Jianghuai Famous Doctor in its fourth edition. He is the Administrative Director of the Obstetrics and Gynecology Department at the First Affiliated Hospital of the University of Science and Technology of China. Dr. Zhao has published over 40 papers, including more than 10 SCI papers, and has applied for 8 patents. He has undertaken 7 national and provincial-level projects and received first, second, and third prizes in the Anhui Provincial Science and Technology Progress Awards.
Contact Information
E-mail: vctorzhao@ustc.tsg211.com
Phone: 0551-62283954
Education and Work Experience
- 1988–1993: Wannan Medical College, Clinical Medicine, Bachelor
- 2001–2004: Anhui Medical University, Obstetrics and Gynecology, Master
- 2011–2014: Shandong University, Clinical Medicine, PhD
- 1993–1998: Anhui Provincial Hospital, Department of Obstetrics and Gynecology, Physician
- 1998–2005: Anhui Provincial Hospital, Department of Obstetrics and Gynecology, Attending Physician
- 2005–2011: Anhui Provincial Hospital, Department of Obstetrics and Gynecology, Deputy Chief Physician
- 2011–2017: Anhui Provincial Hospital, Department of Obstetrics and Gynecology, Chief Physician
- 2017–Present: First Affiliated Hospital of the University of Science and Technology of China, Chief Physician
Academic Achievements and Impact
Dr. Zhao has dedicated nearly 30 years to teaching and researching gynecological tumors and reproductive tract diseases, having trained 45 PhD and master's students. He received the first prize in the Anhui Provincial Science and Technology Progress Award in 2020, the second prize in 2009, and the third prize in 2006. He has published over 10 SCI papers in journals such as ACS Applied Materials & Interfaces, BioMed Research International, Journal of Obstetrics and Gynaecology Research, and Frontiers in Oncology, with a total citation count of over 100.
Current Research Projects (Main Responsible Person Only)
- Title: Molecular Mechanism of p63/circHERC4/miR-155 Axis Regulating Platinum Resistance in Cervical Cancer Cells
Source: National Natural Science Foundation Project
Funding: 540,000 RMB
Duration: 2022-01 to 2025-12
- Title: Impact of Corynebacterium and Its CAMP Factor on Vaginal Microenvironment, Bacterial Vaginosis, and HPV Susceptibility and Its Molecular Mechanisms
Source: USTC New Medicine Joint Fund Project
Funding: 800,000 RMB
Duration: 2021-01 to 2023-12
- Title: AI-Assisted Diagnosis Driven by Multimodal Data
Source: Anhui University Collaborative Innovation Project
Funding: 80,000 RMB
Duration: 2019-01 to 2022-12
Representative Papers (Last Five Years)
1. Chen Y, Wu H, Zhou H, Miao Z, Hong F, Zhao Q, Tao Z, Ma Y, Zhao W*, Zha Z*. PEGylated Indium Nanoparticles: A Metallic Contrast Agent for Multiwavelength Photoacoustic Imaging and Second Near-Infrared Photothermal Therapy. ACS Applied Materials & Interfaces 2021, 13(39):46343-46352.
2. Chen Y, Lin H, Pi YN, Chen XX, Zhou H, Tian Y, Zhao WD*, Xia BR*. Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer. Front Oncol 2021, 11:616530.
3. Jin Q, Huang L, Zhao W*. Stage IVA ovarian cancer one year following the third In Vitro Fertilisation procedure. J Pak Med Assoc 2021, 71(4):1270-1272.
4. Gui Y, Wang L, Gao T, Hong H, Zhao W*. Ultrasonic Imaging Combined with Hysteroscopy in Diagnosis of Endometrial Polyps Based on Multioperator Algorithm and Analysis of Nerve Growth Factor Receptor Transmembrane Protein Expression. World Neurosurgery 2021, 149:413-419.
5. Wu X, Chen Z, Ren P, Zhao X, Tang D, Geng H, Xu X*, Zhao W*. Identifying Sequence Variants of 18 Hereditary Ovarian Cancer-Associated Genes in Chinese Epithelial Ovarian Cancer Patients. Biomed Res Int 2021, 2021:5579543.
6. Xia X, Jiang W, Qi W, Hong B, Zhao W*. Clinical Efficacy and Safety of Apatinib for the Treatment of Patients with Metastatic, Recurrent Cervical Cancer after Failure of Radiotherapy and First-Line Chemotherapy: A Prospective Study. Oncology Research and Treatment 2020, 43(12):649-655.
7. Zhang Y, Zhao W*, Chen Z, Zhao X, Ren P, Zhu M. Establishment and Evaluation of a Risk-Scoring System for Lymph Node Metastasis in Early-Stage Endometrial Carcinoma: Achieving Preoperative Risk Stratification. J Obstet Gynaecol Res 2020, 46(11):2305-2313.